Catalyst Biosciences

About:

Catalyst Biosciences is a biopharmaceutical company that offers protease therapeutics to address disorders of the coagulation system.

Website: http://www.catalystbiosciences.com

Twitter/X: catalystbio

Top Investors: Sofinnova Investments, New Enterprise Associates, Novartis Venture Fund, Morgenthaler Ventures, Oxford Bioscience Partners

Description:

Catalyst Biosciences is a research and clinical development biopharmaceutical company. They focus on addressing unmet medical needs in rare disorders of the complement and coagulation systems. They create novel catalytic biopharmaceutical products based on engineered human proteases.

Total Funding Amount:

$301M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

1997-01-01

Contact Email:

info(AT)catbio.com

Founders:

Charles S. Craik, Christopher Thanos, Jack Nguyen, Sandra Waugh Ruggles

Number of Employees:

51-100

Last Funding Date:

2021-01-27

IPO Status:

Public

© 2025 bioDAO.ai